Thoratec Corporation
23
0
0
18
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
17.4%
4 terminated/withdrawn out of 23 trials
81.8%
-4.7% vs industry average
4%
1 trials in Phase 3/4
50%
9 of 18 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (23)
HeartMate 3 ELEVATE™ Registry
Role: collaborator
Inhaled Milrinone Use in Patients Receiving HeartMate II LVAD: A Pilot Study
Role: collaborator
Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial
Role: collaborator
Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation
Role: collaborator
HeartMate 3™ CE Mark Clinical Investigation Plan
Role: collaborator
Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy
Role: collaborator
MOMENTUM 3 IDE Clinical Study Protocol
Role: collaborator
CentriMag RVAS U.S. Post-approval Study Protocol
Role: collaborator
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass
Role: collaborator
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management
Role: collaborator
HeartMate 3™ LIS Study
Role: collaborator
CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass for Pediatric Patients
Role: collaborator
Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Management Study
Role: collaborator
PREVENtion of HeartMate II Pump Thrombosis
Role: collaborator
Driveline Silicone Skin Interface Registry
Role: collaborator
BeneMACS Study:HeartMate 2 (HM2)Left Ventricular Assist Device (LVAD) Survival in Non Transplant Patients is Equal/Better Than Results in Medical Literature
Role: collaborator
Frailty: Prevalence and Response to Left Ventricular Assist Device Therapy in Older Heart Failure Patients
Role: collaborator
Bone Marrow-derived Mesenchymal Stem Cells (MSC) Administration in Weaning From Left Ventricular Assist Device
Role: collaborator
Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure
Role: collaborator
Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD).
Role: collaborator